Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology
Ther Innov Regul Sci
.
2020 Sep;54(5):1225-1226.
doi: 10.1007/s43441-020-00150-2.
Authors
Noraisyah Mohd Sani
1
,
Neil McAuslane
2
,
Siti Hidayah Kasbon
1
,
Rosilawati Ahmad
1
,
Faridah Aryani Md Yusof
1
,
Prisha Patel
3
Affiliations
1
National Pharmaceutical Regulatory Agency, Lot 36, Jalan Universiti, 46200, Petaling Jaya, Selangor, Malaysia.
2
Centre for Innovation in Regulatory Science (CIRS), 160 Blackfriars Road, London, SE18EZ, UK. nmcauslane@cirsci.org.
3
Centre for Innovation in Regulatory Science (CIRS), 160 Blackfriars Road, London, SE18EZ, UK.
PMID:
32865806
PMCID:
PMC7645581
DOI:
10.1007/s43441-020-00150-2
Abstract
The authors have revised Figure 1. The revised figure is presented below.
Publication types
Published Erratum